Dennis M. Mcgrath - 07 Feb 2023 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Director
Signature
/s/ Alexander M. Donaldson, by power of attorney
Issuer symbol
CTXR
Transactions as of
07 Feb 2023
Net transactions value
$0
Form type
4
Filing time
09 Feb 2023, 15:06:16 UTC
Previous filing
23 Dec 2022
Next filing
12 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Options to Purchase Common Stock Award $0 +75,000 $0.000000 75,000 07 Feb 2023 Common Stock 75,000 $1.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on February 7, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.